Takahiro Ikeda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Takahiro Ikeda has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
C. Mitsuhata
Department of Pharmacology, Hiroshima University School of Dentistry, Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553, Japan
1 shared publication- Kenichi Morita
Hiroshima University
1 shared publication S. Kitayama
Department of Pharmacology, Hiroshima University School of Dentistry, Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553, Japan
1 shared publicationT. Dohi
Department of Pharmacology, Hiroshima University School of Dentistry, Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553, Japan
1 shared publication- Takeo Arai
Toyota Central R&D Labs., Inc. 41-1 Yokomichi, Nagakute Aichi 480-1192 Japan
1 shared publication - Takeshi Morikawa
Toyota Central Research and Development Laboratories (Japan)
1 shared publication
Latest Publications
- 23 June 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (58) , 8125-8128
Ni-modified β-FeOOH nanorod cocatalysts for oxygen evolution utilising photoexcited holes on a N 2p level in a N-doped TiO2 electrode
Ni-modified β-FeOOH nanorod cocatalysts efficiently utilised the N 2p holes in N-doped TiO2 upon visible light irradiation.
- 23 June 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (58) , 8125-8128
Ni-modified β-FeOOH nanorod cocatalysts for oxygen evolution utilising photoexcited holes on a N 2p level in a N-doped TiO2 electrode
Ni-modified β-FeOOH nanorod cocatalysts efficiently utilised the N 2p holes in N-doped TiO2 upon visible light irradiation.
- 1 February 2000
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 361 (2) , 214-220
Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics
Synthetic local anesthetics (LAs) have been found to have cocaine-like characteristics with some psychotomimetic action, possibly through monoaminergic neurotransmission. To gain insight into the relation between LA action and monoamine transporters, we investigated the effect of synthetic LAs on neurotransmitter transporters, including monoamine transporters. We used cloned transporter cDNAs and examined transient functional expression in COS cells and stable expression in HeLa cells. Among the LAs tested, procaine and other ester-type LAs inhibited [3H]DA uptake and binding of [3H]2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane (CFT), a cocaine analogue, in COS cells expressing rat dopamine transporter (DAT). The inhibition was concentration-dependent. The inhibitory effect on [3H]DA uptake was reversible and not dependent on pH, as observed in HeLa cells stably expressing DAT. Procaine also inhibited uptake of norepinephrine (NE) and serotonin (5-HT) by the norepinephrine transporter (NET) or serotonin transporter (SERT) expressed in COS cells. On the other hand, procaine and other LAs had little or no effect on [3H]GABA and [3H]glutamate uptake in COS cells expressing mouse GABA or rat glutamate/aspartate transporter. IC50 values for [3H]DA uptake inhibition correlated well with those for [3H]CFT binding inhibition, but not with intrinsic anesthetic potency. Kinetic analysis of monoamine uptake inhibition by procaine in COS cells expressing rat DAT, NET or SERT revealed a competitive action similar to that of cocaine. These results demonstrate that certain LAs selectively inhibit monoamine transporters. This might contribute to the cocaine-like psychotomimetic action of certain LAs.
- 1 February 2000
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 361 (2) , 214-220
Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics
Synthetic local anesthetics (LAs) have been found to have cocaine-like characteristics with some psychotomimetic action, possibly through monoaminergic neurotransmission. To gain insight into the relation between LA action and monoamine transporters, we investigated the effect of synthetic LAs on neurotransmitter transporters, including monoamine transporters. We used cloned transporter cDNAs and examined transient functional expression in COS cells and stable expression in HeLa cells. Among the LAs tested, procaine and other ester-type LAs inhibited [3H]DA uptake and binding of [3H]2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane (CFT), a cocaine analogue, in COS cells expressing rat dopamine transporter (DAT). The inhibition was concentration-dependent. The inhibitory effect on [3H]DA uptake was reversible and not dependent on pH, as observed in HeLa cells stably expressing DAT. Procaine also inhibited uptake of norepinephrine (NE) and serotonin (5-HT) by the norepinephrine transporter (NET) or serotonin transporter (SERT) expressed in COS cells. On the other hand, procaine and other LAs had little or no effect on [3H]GABA and [3H]glutamate uptake in COS cells expressing mouse GABA or rat glutamate/aspartate transporter. IC50 values for [3H]DA uptake inhibition correlated well with those for [3H]CFT binding inhibition, but not with intrinsic anesthetic potency. Kinetic analysis of monoamine uptake inhibition by procaine in COS cells expressing rat DAT, NET or SERT revealed a competitive action similar to that of cocaine. These results demonstrate that certain LAs selectively inhibit monoamine transporters. This might contribute to the cocaine-like psychotomimetic action of certain LAs.